We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$3.64B
1-Year Est. Return
83.38%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+83.38%
3 Year Est. Return
+239.61%
5 Year Est. Return
+330.19%
10 Year Est. Return
+1,383.86%
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.43B
Cap. Flow
% of AUM
101.06%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
1,386
New
1,386
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$41.1M |
| 2 |
Amgen
AMGN
|
+$40.3M |
| 3 |
AbbVie
ABBV
|
+$32.9M |
| 4 |
ExxonMobil
XOM
|
+$26.5M |
| 5 |
Biogen
BIIB
|
+$26.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.73% |
| 2 | Technology | 11.77% |
| 3 | Energy | 10.48% |
| 4 | Financials | 10.3% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTG
1376
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
| $21K | ﹤0.01% |
+10,440
| New | +$18.6K |
|
|
CGRN
1377
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $19K | ﹤0.01% |
+83
| New | +$16.6K |
|
1378
Quantum Corp
QMCO
$975M
| $17K | ﹤0.01% |
+76
| New | +$17K |
|
|
STSI
1379
DELISTED
STAR SCIENTIFIC INC
STSI
| $15K | ﹤0.01% |
+10,730
| New | +$14.8K |
|
|
DVAX
1380
DELISTED
Dynavax Technologies
DVAX
| $13K | ﹤0.01% |
+1,218
| New | +$25.7K |
|
1381
FuelCell Energy
FCEL
$1.2B
| $13K | ﹤0.01% |
+2
| New | +$9.89K |
|
1382
Paramount Gold Nevada
PZG
$121M
| $12K | ﹤0.01% |
+10,440
| New | +$15.8K |
|
|
MDW
1383
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
| $10K | ﹤0.01% |
+10,150
| New | +$10.2K |
|
|
DRL
1384
DELISTED
DORAL FINANCIAL CORPORATION (NEW)
DRL
| $9K | ﹤0.01% |
+566
| New | +$10.1K |
|
|
SWSH
1385
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
| $9K | ﹤0.01% |
+1,073
| New | +$12.2K |
|
Similar funds
VGM
WPC
QCG
CC
AWE
LIP
HIMC
ISL
Profund Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Profund Advisors, which disclosed 1,386 positions worth $1.42B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Gilead Sciences: 789,103 shares worth $40.4M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Energy.
- Profund Advisors's largest Q2 2013 buy was Gilead Sciences: 789,103 shares worth $40.4M.
- Profund Advisors's ten largest holdings make up 19% of its $1.42B portfolio in Q2 2013.
- Profund Advisors disclosed 1,386 positions in Q2 2013, its first 13F filing on record.
Based on Profund Advisors's 13F filing for Q2 2013, filed 25 Jul 2013.